• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结核分枝杆菌肺病辅助手术的疗效

Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease.

作者信息

Kim Joong-Yub, Park Samina, Park In Kyu, Kang Chang Hyun, Kim Young Tae, Koh Jaemoon, Yim Jae-Joon, Kwak Nakwon

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.

Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, South Korea.

出版信息

BMC Pulm Med. 2021 Oct 6;21(1):312. doi: 10.1186/s12890-021-01679-0.

DOI:10.1186/s12890-021-01679-0
PMID:34615499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8496107/
Abstract

BACKGROUND

Owing to the unsatisfactory results of antibiotic treatment alone, surgical resection is currently considered as adjunctive therapy in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD). However, reports regarding the outcomes of surgery vary considerably by institution. Here, we investigated the surgical outcomes and risk factors associated with unfavorable outcomes after surgery.

METHODS

We analyzed patients with NTM-PD who underwent pulmonary resection at Seoul National University Hospital between January 1, 2006, and December 31, 2020, and assessed the types of surgical procedures, complications, and long-term outcomes. Multivariate logistic regression analysis was used to identify the risk factors associated with treatment refractoriness or recurrence after surgery.

RESULTS

Among 67 patients who underwent surgery during the study period, the most common indication for surgery was persistent culture positivity despite rigorous medical treatment (80.6%), followed by longstanding cavitary lesions or radiographic aggravation (10.4%) and massive hemoptysis (4.5%). Among 53 patients with positive mycobacterial cultures at the time of surgery, 38 (71.7%) achieved initial negative culture conversion, 9 (17.0%) of whom experienced recurrence. Nine (13.4%) patients experienced postoperative complications, which were managed without lasting morbidity and mortality. Female sex (adjusted odds ratio [aOR] 6.63; 95% confidence interval [CI] 1.04-42.4; P = .046), preoperative positive mycobacterial culture (aOR 5.87; 95 %CI 1.04-33.08; P = .045), and residual lesions (aOR 6.86; 95 %CI 1.49-31.56; P = .013) were associated with refractoriness or recurrence.

CONCLUSIONS

Pulmonary resection is a reasonable treatment modality for patients with refractory NTM-PD or major complications such as massive hemoptysis. The potential risk factors associated with unfavorable outcomes included female sex, preoperative positive mycobacterial culture, and residual lesions after surgery.

摘要

背景

由于单纯抗生素治疗效果不理想,手术切除目前被视为非结核分枝杆菌肺病(NTM-PD)患者的辅助治疗方法。然而,不同机构关于手术结果的报告差异很大。在此,我们调查了手术结果以及与术后不良结果相关的危险因素。

方法

我们分析了2006年1月1日至2020年12月31日在首尔国立大学医院接受肺切除的NTM-PD患者,并评估了手术方式、并发症和长期结果。采用多因素逻辑回归分析确定与术后治疗难治性或复发相关的危险因素。

结果

在研究期间接受手术的67例患者中,最常见的手术指征是尽管进行了严格的药物治疗但培养仍持续阳性(80.6%),其次是长期空洞性病变或影像学加重(10.4%)和大量咯血(4.5%)。在手术时结核分枝杆菌培养阳性的53例患者中,38例(71.7%)实现了初始培养转阴,其中9例(17.0%)复发。9例(13.4%)患者出现术后并发症,经处理后未出现持续的发病率和死亡率。女性(调整优势比[aOR]6.63;95%置信区间[CI]1.04 - 42.4;P = 0.046)、术前结核分枝杆菌培养阳性(aOR 5.87;95%CI 1.04 - 33.08;P = 0.045)和残留病变(aOR 6.86;95%CI 1.49 - 31.56;P = 0.013)与难治性或复发相关。

结论

肺切除对于难治性NTM-PD或诸如大量咯血等主要并发症的患者是一种合理的治疗方式。与不良结果相关的潜在危险因素包括女性、术前结核分枝杆菌培养阳性和术后残留病变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eeb/8496107/51c4b5d88b90/12890_2021_1679_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eeb/8496107/51c4b5d88b90/12890_2021_1679_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eeb/8496107/51c4b5d88b90/12890_2021_1679_Fig1_HTML.jpg

相似文献

1
Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病辅助手术的疗效
BMC Pulm Med. 2021 Oct 6;21(1):312. doi: 10.1186/s12890-021-01679-0.
2
Pulmonary resection for nontuberculous mycobacterial pulmonary disease: outcomes and risk factors for recurrence.非结核分枝杆菌肺病的肺切除术:结局和复发的危险因素。
Gen Thorac Cardiovasc Surg. 2020 Sep;68(9):993-1002. doi: 10.1007/s11748-020-01326-1. Epub 2020 Mar 7.
3
Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease.非结核分枝杆菌性肺病的肺切除术后长期结果。
Clin Infect Dis. 2017 Jul 15;65(2):244-251. doi: 10.1093/cid/cix274.
4
Treatment outcomes of adjuvant resectional surgery for nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病辅助性切除手术的治疗结果
BMC Infect Dis. 2015 Feb 19;15:76. doi: 10.1186/s12879-015-0823-1.
5
Adjuvant surgical treatment of nontuberculous mycobacterial lung disease.非结核分枝杆菌肺病的辅助外科治疗。
Ann Thorac Surg. 2013 Jul;96(1):287-91. doi: 10.1016/j.athoracsur.2013.03.008. Epub 2013 Apr 22.
6
Extensive Lung Resection for Nontuberculous Mycobacterial Lung Disease With Multilobar Lesions.广泛肺切除术治疗多叶病变的非结核分枝杆菌肺病
Ann Thorac Surg. 2021 Jan;111(1):253-260. doi: 10.1016/j.athoracsur.2020.05.067. Epub 2020 Jul 1.
7
Outcomes of Adjunctive Surgery in Patients With Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Review and Meta-analysis.非结核分枝杆菌肺病患者辅助手术的结局:一项系统评价和荟萃分析
Chest. 2023 Apr;163(4):763-777. doi: 10.1016/j.chest.2022.09.037. Epub 2022 Oct 5.
8
Prognosis of nontuberculous mycobacterial pulmonary disease according to the method of microbiologic diagnosis.根据微生物学诊断方法判断非结核分枝杆菌肺病的预后。
Sci Rep. 2021 Apr 13;11(1):8036. doi: 10.1038/s41598-021-87197-9.
9
Usefulness of Post-bronchoscopy Sputum Culture for Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease.支气管镜检查后痰培养对非结核分枝杆菌肺病诊断的效用
J Korean Med Sci. 2021 Aug 9;36(31):e202. doi: 10.3346/jkms.2021.36.e202.
10
Surgical approach to pulmonary nontuberculous mycobacterial infections.肺部非结核分枝杆菌感染的手术治疗方法。
Clin Chest Med. 2015 Mar;36(1):117-22. doi: 10.1016/j.ccm.2014.11.004. Epub 2014 Dec 19.

引用本文的文献

1
Early surgical intervention for extensive nontuberculous mycobacterial pulmonary disease.广泛非结核分枝杆菌肺病的早期手术干预
IJTLD Open. 2025 Jul 9;2(7):412-419. doi: 10.5588/ijtldopen.25.0127. eCollection 2025 Jul.
2
Significance of changes in cavity after treatment in Mycobacterium avium complex pulmonary disease.分枝杆菌复合群肺病治疗后空洞变化的意义。
Sci Rep. 2024 Sep 10;14(1):21133. doi: 10.1038/s41598-024-71971-6.
3
Immunologic features of nontuberculous mycobacterial pulmonary disease based on spatially resolved whole transcriptomics.

本文引用的文献

1
Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease.非结核分枝杆菌感染后的慢性肺曲霉病:一种新兴疾病。
J Fungi (Basel). 2020 Dec 8;6(4):346. doi: 10.3390/jof6040346.
2
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.非结核分枝杆菌肺病治疗:美国胸科学会/欧洲呼吸学会/欧洲临床微生物学和传染病学会/美国感染病学会临床实践指南
Clin Infect Dis. 2020 Aug 14;71(4):e1-e36. doi: 10.1093/cid/ciaa241.
3
Extensive Lung Resection for Nontuberculous Mycobacterial Lung Disease With Multilobar Lesions.
基于空间分辨全转录组学的非结核分枝杆菌肺病的免疫学特征。
BMC Pulm Med. 2024 Aug 13;24(1):392. doi: 10.1186/s12890-024-03207-2.
4
Adjuvant surgical treatment of non-tuberculous mycobacterial lung disease in chronic thromboembolic pulmonary hypertension: A first case report.慢性血栓栓塞性肺动脉高压合并非结核分枝杆菌肺病的辅助手术治疗:首例病例报告
J Clin Tuberc Other Mycobact Dis. 2024 Jul 2;36:100462. doi: 10.1016/j.jctube.2024.100462. eCollection 2024 Aug.
5
Adjuvant surgical resection for nontuberculous mycobacterial pulmonary disease: Effectiveness and complications.非结核分枝杆菌肺病的辅助性手术切除:有效性及并发症
Ann Thorac Med. 2024 Apr-Jun;19(2):131-138. doi: 10.4103/atm.atm_237_23. Epub 2024 Apr 25.
6
Beyond antibiotics: recent developments in the diagnosis and management of nontuberculous mycobacterial infection.超越抗生素:非结核分枝杆菌感染诊断与管理的最新进展
Breathe (Sheff). 2022 Jun;18(2):210171. doi: 10.1183/20734735.0171-2021. Epub 2022 Jul 12.
7
Nontuberculous Mycobacteria Lung Disease (NTM-LD): Current Recommendations on Diagnosis, Treatment, and Patient Management.非结核分枝杆菌肺病(NTM-LD):关于诊断、治疗和患者管理的当前建议
Int J Gen Med. 2022 Oct 1;15:7619-7629. doi: 10.2147/IJGM.S272690. eCollection 2022.
广泛肺切除术治疗多叶病变的非结核分枝杆菌肺病
Ann Thorac Surg. 2021 Jan;111(1):253-260. doi: 10.1016/j.athoracsur.2020.05.067. Epub 2020 Jul 1.
4
The impact of adjuvant surgical treatment of nontuberculous mycobacterial pulmonary disease on prognosis and outcome.非结核分枝杆菌肺病辅助手术治疗对预后和结局的影响。
Respir Res. 2020 Jun 16;21(1):153. doi: 10.1186/s12931-020-01420-1.
5
Residual Destructive Lesions and Surgical Outcome in Mycobacterium avium Complex Pulmonary Disease.鸟分枝杆菌复合群肺病中的残留破坏性病变与手术结果
Ann Thorac Surg. 2020 Nov;110(5):1698-1705. doi: 10.1016/j.athoracsur.2020.04.034. Epub 2020 May 28.
6
Pulmonary resection for nontuberculous mycobacterial pulmonary disease: outcomes and risk factors for recurrence.非结核分枝杆菌肺病的肺切除术:结局和复发的危险因素。
Gen Thorac Cardiovasc Surg. 2020 Sep;68(9):993-1002. doi: 10.1007/s11748-020-01326-1. Epub 2020 Mar 7.
7
pulmonary disease: individual patient data meta-analysis.肺病:个体患者数据荟萃分析。
Eur Respir J. 2019 Jul 11;54(1). doi: 10.1183/13993003.01991-2018. Print 2019 Jul.
8
Surgical Treatment of Pulmonary Nontuberculous Mycobacterial Infections.肺部非结核分枝杆菌感染的外科治疗
Thorac Surg Clin. 2019 Feb;29(1):77-83. doi: 10.1016/j.thorsurg.2018.09.011.
9
Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease.鸟分枝杆菌复合群肺病辅助手术治疗后的结局和危险因素
Gen Thorac Cardiovasc Surg. 2019 Apr;67(4):363-369. doi: 10.1007/s11748-018-1029-4. Epub 2018 Nov 2.
10
Adjuvant lung resection in the management of nontuberculous mycobacterial lung infection: A retrospective matched cohort study.辅助性肺切除术在非结核分枝杆菌肺部感染治疗中的应用:一项回顾性匹配队列研究。
Respir Med. 2018 Sep;142:1-6. doi: 10.1016/j.rmed.2018.07.003. Epub 2018 Jul 9.